Biosafety rules will regulate international GMO transfers

GMO biosafety research in China.

Over the years, genetically modified organism (GMO) development and regulation in China have regularly attracted international attention. In the early 1990s, China became the first country to commercialize a genetically modified (GM) crop with planting of a virus-resistant transgenic tobacco variety on a relatively large scale, while other parts of the world were debating about the risks of GMO...

Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations

Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidity and mortality worldwide. Several TB vaccine candidates are currently in clinical and preclinical development. They fall into two categories, the one of candidates designed as a replacement of the Bacille Calmette Guérin (BCG) to be administered to infants and the one of sub-unit vaccines designed as boo...

Growth, trade, and international transfers

This paper analyzes the simplest neoclassical economy in which agents have finite lives and there is sustained per capita growth. The growth rate of the world economy depends upon countries' savings propensities and common technology. Trade can reverse an economy's autarkic growth trajectory, and a country with a high savings rate runs a current account surplus. If a surplus country expands agg...

GMO Regulations, International Trade and the Imperialism of Standards

This paper deals with the quantification of GMO regulations on bilateral trade flows. A composite index of the ‘complexity’ of such regulations for sixty countries as well as an ‘objective’ score for six GMO regulatory sub-dimensions has been developed. Using a gravity model, we show how bilateral ‘similarity’ in GMO regulations, affect trade flows for the composite index and its components. Re...

Descent Rules and Inter Vivos Transfers